pyruvic acid has been researched along with bms 806 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clapham, P; Colonno, R; Dalterio, R; Dicker, I; Fan, L; Fang, H; Gong, YF; Ho, HT; Kadow, J; Li, CB; Lin, PF; Matiskella, J; McAuliffe, B; Nowicka-Sans, B; Robinson, J; Ueda, Y; Wang, T; Yamanaka, G; Yin, Z; Zhou, N | 1 |
| Bender, JA; Colonno, RJ; D'Arienzo, CJ; Dicker, IB; DiGiugno Parker, D; Eggers, BJ; Fan, L; Fang, H; Gao, Q; Gesenberg, C; Gong, YF; Ho, HT; Johnson, G; Kadow, JF; Lin, PF; McAuliffe, BV; Meanwell, NA; Nowicka-Sans, B; Wang, T; Yamanaka, GA; Yang, Z; Yin, Z; Zadjura, LM; Zhang, Z; Zhou, N | 1 |
2 other study(ies) available for pyruvic acid and bms 806
| Article | Year |
|---|---|
Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events.
Topics: Anti-HIV Agents; CD4 Antigens; HeLa Cells; HIV Envelope Protein gp120; HIV-1; Humans; Indoles; Piperazines; Protein Conformation; Pyruvic Acid; Virion | 2006 |
Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a drug ca
Topics: Animals; Anti-HIV Agents; Cell Line; Drug Discovery; HIV Infections; HIV-1; Humans; Indoles; Models, Molecular; Molecular Conformation; Piperazines; Pyruvic Acid; Rats; Reproducibility of Results; Virus Attachment | 2009 |